Bottom line
HCPSX vs RXL: the short answer
HCPSX (Health Care Ultrasector Profund) and RXL (ProShares Ultra Health Care) are both mutual funds.
RXL is cheaper at 0.95% vs 2.76% — a difference of $181 a year per $10,000 invested.
Over five years, RXL returned +7.2% a year vs +5.3% for HCPSX (reporting dates differ).
Updated Nov 19, 2026
HCPSX vs RXL side by side
| HCPSX | RXL | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | ProShares | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.76% | 0.95% |
| Annual cost per $10k | $276 | $95 |
| 10-yr cost on $10k (prospectus) | $3,090 | $1,305 |
| Max front load | — | None |
| 12b-1 fee | 1% | — |
| 1-yr return | −2.4% | +19.7% |
| 5-yr return (annualized) | +5.3% | +7.2% |
| 10-yr return (annualized) | +8.1% | +12.6% |
| Best quarter | — | +29.7% |
| Worst quarter | — | −28.9% |
| Net assets (fund) | $12.1M | $72.1M |
| Number of holdings | 69 | 70 |
| Portfolio turnover | 99% | 4% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of HCPSX's top 25 holdings also appear in RXL's top 25.
| Holding | HCPSX | RXL |
|---|---|---|
| Eli Lilly & Company | 11.83% | 12.67% |
| Johnson & Johnson | 8.03% | 7.86% |
| Abbvie Inc | 5.77% | 5.57% |
| Unitedhealth Group Inc | 4.90% | 4.98% |
| Merck & Company Inc | 4.19% | 4.26% |
| Thermo Fisher Scientific Inc | 2.78% | 2.68% |
| Amgen Inc | 2.71% | 2.62% |
| Abbott Laboratories | 2.40% | 2.15% |
| Gilead Sciences Inc | 2.10% | 2.41% |
| Pfizer Inc | 1.86% | 2.15% |
| Bristol-myers Squibb Company | 1.74% | 1.68% |
| Cvs Health Corp | 1.73% | 1.67% |
| Intuitive Surgical Inc | 1.63% | 2.18% |
| Danaher Corp | 1.60% | 1.66% |
| Vertex Pharmaceuticals Inc | 1.57% | 1.64% |
Source: SEC Form N-PORT
HCPSX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
RXL top 10
- Eli Lilly & Co. — 12.67%
- ProShares GENIUS Money Market ETF — 11.81%
- Johnson & Johnson — 7.86%
- AbbVie, Inc. — 5.57%
- UnitedHealth Group, Inc. — 4.98%
- Merck & Co., Inc. — 4.26%
- Repurchase Agreement — 2.91%
- Thermo Fisher Scientific, Inc. — 2.68%
- Amgen, Inc. — 2.62%
- Gilead Sciences, Inc. — 2.41%
FAQ
What is the difference between HCPSX and RXL?
HCPSX (Health Care Ultrasector Profund) and RXL (ProShares Ultra Health Care) are both mutual funds. RXL is cheaper at 0.95% vs 2.76% — a difference of $181 a year per $10,000 invested.
Which is cheaper, HCPSX or RXL?
RXL has the lower expense ratio (0.95%).
Should I own both HCPSX and RXL?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.